Moderna: Pipeline Hope Won't Pay The Bills [Seeking Alpha]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Seeking Alpha
MRNA's pipeline offers long-term promise, notably the melanoma vaccine with a pivotal Phase 3 readout in late 2026, but near-term revenue remains dominated by declining COVID sales. The recent $2.25 billion patent settlement removes a legal overhang but accelerates cash depletion, increasing the risk of future capital raises, in my opinion. Given high valuation, competitive pressures, and pipeline uncertainty, I rate MRNA a Sell, seeing more downside risk than upside at current levels. hapabapa/iStock Editorial via Getty Images Introduction Moderna, Inc. ( MRNA ) has been in the doldrums ever since the COVID-19 pandemic ended, as it has suffered from the lack of tailwinds ever since. The pharma company has seen its revenue shrink every This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myse
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Looking for Small-Cap Value? Consider These 2 ETFs [Yahoo! Finance]Yahoo! Finance
- The 20 stocks hedge funds love to short [Seeking Alpha]Seeking Alpha
- Spikevax (Moderna) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Is BioNTech SE (BNTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/13/26 - Beat
MRNA
Sec Filings
- 3/16/26 - Form DEFA14A
- 3/16/26 - Form DEF
- 3/16/26 - Form ARS
- MRNA's page on the SEC website